Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Find practical ways to generate income for debt relief. Empower yourself with options that can help alleviate financial burdens.
18,423 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
A veteran wealth manager makes a bold move into defense stocks as geopolitical tensions rise. Learn the strategy, ris...
Investors noticed a notable move in Ross Stores shares as the off-price retailer reported stronger results and a heal...
Visa and Mastercard are reportedly pursuing a stablecoin platform with Stripe and Coinbase, a move that could alter h...
Dave & Buster's is blending food, drinks, and arcade play into a growing business model. This analysis breaks down th...
Hedge funds buying amazon can hint at value in a complex market. This guide breaks down what the trend may mean for y...
As AI romance apps grow, couples and singles are juggling digital affection with real budgets. Learn how crypto payme...
Ethereum confirms FOCIL will join the Hegota upgrade in 2026 while the Ethereum Foundation redirects a portion of its...
NIO’s stock surged this week on improving fundamentals and a better-than-expected outlook. This article breaks down t...
In stock market today, march, Grab surprised investors with a substantial buyback and a bold Foodpanda expansion. Thi...
In the race to redefine urban air mobility, Joby Aviation and Archer Aviation stand out. This article highlights thre...
A mid-2026 move by a hedge fund to exit EPAM Systems sparked questions about portfolio risk and disclosure. This guid...